IL222772D0
Pharmaceutical compositions comprising hydromorphone and naloxone
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
54 members in 31 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 10162428 | European Patent Office (EPO) | A | |
| 2011057566 | European Patent Office (EPO) | W | |
| 101624286 | – | – | – |
| EP20100162428 | – | – | – |
| PCTEP2011057566 | – | – | – |
| WO2011EP57566 | – | – | – |
Members54
| Document | Office | Kind | |
|---|---|---|---|
| CA2739751A1 | Canada | A1 | |
| WO2011141488A2 | World Intellectual Property Organization (WIPO) | A2 | |
| TW201206501A | Taiwan Province of China | A | |
| WO2011141488A3 | World Intellectual Property Organization (WIPO) | A3 | |
| DK201270677A | Denmark | A | |
| AU2011252039A1 | Australia | A1 | |
| SG184523A1 | Singapore | A1 | |
| GB201219275D0 | United Kingdom | D0 | |
| GB2492037A | United Kingdom | A | |
| SE1251371A1 | Sweden | A1 | |
| AP2012006606A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| IL222772A0 | Israel | A0 | |
| IL222772D0This record | Israel | D0 | |
| AR083150A1 | Argentina | A1 | |
| MX2012013119A | Mexico | A | |
| NO20121414A1 | Norway | A1 | |
| CN102946870A | China | A | |
| ECSP12012236A | Ecuador | A | |
| CR20120549A | Costa Rica | A | |
| EP2568967A2 | European Patent Office (EPO) | A2 | |
| CO6640216A2 | Colombia | A2 | |
| KR20130030260A | Republic of Korea | A | |
| DE112011101605T5 | Germany | T5 | |
| EA201291211A1 | Eurasian Patent Organization (EAPO) | A1 | |
| ES2408343A2 | Spain | A2 | |
| JP2013526508A | Japan | A | |
| US2013178492A1 | United States of America | A1 | |
| ES2408343R1 | Spain | R1 | |
| TN2012000488A1 | Tunisia | A1 | |
| AU2011252039B2 | Australia | B2 | |
| ES2408343B2 | Spain | B2 | |
| UA106278C2 | Ukraine | C2 | |
| CA2739751C | Canada | C | |
| ZA201207603B | South Africa | B | |
| TW201503913A | Taiwan Province of China | A | |
| JP5671609B2 | Japan | B2 | |
| NZ603497A | New Zealand | A | |
| KR20150028367A | Republic of Korea | A | |
| TWI483748B | Taiwan Province of China | B | |
| NZ700732A | New Zealand | A | |
| AP3441A | African Regional Intellectual Property Organization (ARIPO) | A | |
| CH705273B1 | Switzerland | B1 | |
| MY157673A | Malaysia | A | |
| BR112012028773A2 | Brazil | A2 | |
| CN105832687A | China | A | |
| DK178741B1 | Denmark | B1 | |
| MX347105B | Mexico | B | |
| TWI590835B | Taiwan Province of China | B | |
| US9700508B2 | United States of America | B2 | |
| KR101858797B1 | Republic of Korea | B1 | |
| EP2568967B1 | European Patent Office (EPO) | B1 | |
| IL222772A | Israel | A | |
| IL222772B | Israel | B | |
| EP2568967B2 | European Patent Office (EPO) | B2 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent not in force due to non-payment of renewal feesMM9K | MM9K | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication, DOCDB
- 222772
- Publication, EPODOC
- IL222772D
- Application
- 222772
- Application, DOCDB
- 22277212
- Application, EPODOC
- IL20120222772
Titles
- English
- PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE
Classification
- CPC, 18
- A61K9/0002
- A61K9/1676
- A61K9/2054
- A61K9/0053
- A61K9/1635
- A61K9/1652
- A61K9/2027
- A61K9/2095
- A61K9/2846
- A61K9/2866
- A61K9/5078
- A61K31/485
- A61P1/00
- A61P25/04
- A61P29/00
- A61K9/20
- A61K31/135
- A61K2300/00
- IPC, 1
- A61K